Aditxt (NASDAQ:ADTX) Major Shareholder Buys 7,340,178 Shares of Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt bought 7,340,178 shares of the business’s stock in a transaction dated Thursday, June 18th. The shares were bought at an average price of $0.01 per share, with a total value of $73,401.78. Following the completion of the transaction, the insider owned 2,406,438 shares in the company, valued at approximately $24,064.38. This trade represents a -148.78% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Monday, June 22nd, Financial Lp Hrt sold 5,120,480 shares of Aditxt stock. The stock was sold at an average price of $0.02, for a total value of $102,409.60.
• On Tuesday, June 16th, Financial Lp Hrt sold 3,132,480 shares of Aditxt stock. The stock was sold at an average price of $0.01, for a total value of $31,324.80.
• On Friday, June 12th, Financial Lp Hrt acquired 4,252,767 shares of Aditxt stock. The shares were purchased at an average cost of $0.02 per share, with a total value of $85,055.34.
• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The stock was sold at an average price of $0.06, for a total transaction of $44,127.72.
• On Thursday, June 4th, Financial Lp Hrt bought 843,622 shares of Aditxt stock. The stock was purchased at an average cost of $0.08 per share, for a total transaction of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The shares were purchased at an average price of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The shares were sold at an average price of $8.10, for a total transaction of $3,588.30.

Aditxt Price Performance

ADTX traded down $0.03 during trading on Wednesday, hitting $0.01. 4,650,711,153 shares of the stock traded hands, compared to its average volume of 124,214,039. The business has a 50 day moving average price of $3.16 and a 200 day moving average price of $113.78. Aditxt, Inc. has a twelve month low of $0.00 and a twelve month high of $53,451.08. The company has a market cap of $7,929.40, a price-to-earnings ratio of -0.00 and a beta of 0.84.

Aditxt (NASDAQ:ADTX) last issued its earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Analyst Ratings Changes

A number of research firms have issued reports on ADTX. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aditxt in a research report on Monday, April 20th. Wall Street Zen raised shares of Aditxt to a “sell” rating in a report on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Aditxt presently has a consensus rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.